Peter Madsen - Concepedia

Author

Peter Madsen

Also Known As

P H Madsen, P Madsen, P. H. MADSEN, P. H. Madsen, P. L. Madsen, P. MADSEN, P. Madsen, P.H MADSEN, P.H. Madsen, PETER MADSEN

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Novo Nordisk (Denmark)Aalborg University Hospital University of Copenhagen Pfizer (United States)Odense University Hospital

About

Peter Madsen is an author at Novo Nordisk (Denmark) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	1K
2	Natural Sciences	7	7	501
3	Engineering	1	1	115
4	Health Sciences	1	1	22
5	Public Health	1	1	115

Peter Madsen

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Bioavailability of marine n-3 fatty acid formulations J. Dyerberg, Peter Madsen, Jakob Møllenbach Møller, Prostaglandins Leukotrienes and Essential Fatty Acids Lipid NutritionOmega-3 Fatty AcidAquacultureLipid ResourcePharmacology	2010	241
Small-molecule agonists for the glucagon-like peptide 1 receptor Lotte Bjerre Knudsen, Dan Kiel, Min Teng, Proceedings of the National Academy of Sciences Rat PancreasGlycobiologyInsulin SignalingGastrointestinal Peptide HormoneMolecular Pharmacology	2007	223
Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing Erica Nishimura, Lone Pridal, Tine Glendorf, BMJ Open Diabetes Research & Care	2021	131
Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans Thomas Kjeldsen, František Hubálek, Claudia U. Hjørringgaard, Journal of Medicinal Chemistry EngineeringArtificial PancreasInsulin SignalingMolecular PharmacologyMetabolic Syndrome	2021	115
Dose-Response Studies on the Effect of n-3 Polyunsaturated Fatty Acids on Lipids and Haemostasis Erik Berg Schmidt, Kim Varming, E. Ernst, Thrombosis and Haemostasis Lipid AnalysisNutritionPlasma FibrinogenDietary SupplementationInflammation	1990	115
Dietary Supplementation with co‐3‐Polyunsaturated Fatty Acids Decreases Mononuclear Cell Proliferation and Interleukin‐1β Content but not Monokine Secretion in Healthy and Insulin‐Dependent Diabetic Individuals Jens Mølvig, Flemming Pociot, H. WORSAAE, Scandinavian Journal of Immunology	1991	113
Discovery and Structure−Activity Relationship of the First Non-Peptide Competitive Human Glucagon Receptor Antagonists Peter Madsen, Lotte Bjerre Knudsen, Finn C. Wiberg, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryDrug TargetBiochemistryFunctional Selectivity	1998	92
Optimization of Alkylidene Hydrazide Based Human Glucagon Receptor Antagonists. Discovery of the Highly Potent and Orally Available 3-Cyano-4-hydroxybenzoic Acid [1-(2,3,5,6-Tetramethylbenzyl)-1<i>H</i>-indol-4-ylmethylene]hydrazide Peter Madsen, Anthony Ling, Michael Plewe, Journal of Medicinal Chemistry	2002	87
Changes in Glucose and Fat Metabolism in Response to the Administration of a Hepato-Preferential Insulin Analog Dale S. Edgerton, Mary Courtney Moore, Jason J. Winnick, Diabetes	2014	69
Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor Min Teng, Michael D. Johnson, Christine K. Thomas, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMolecular PhysiologySignal TransductionBiochemistryG Protein-coupled Receptor	2007	63

Page 1